Patent details

Basic Information

Publication number:

EP2510098

PCT Application Number:

PCT/US/2010/059597

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP108091133

PCT Publication Number:

WO/2011/072091

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHODS AND COMPOSITIONS FOR TREATING DISEASES, DISORDERS OR INJURY OF THE CNS

French Title of Invention:

MÉTHODES ET COMPOSITIONS UTILISÉES POUR LE TRAITEMENT DE MALADIES, D'AFFECTIONS OU DE LÉSIONS DU SNC

German Title of Invention:

VERFAHREN UND ZUSAMMENSETZUNGEN UND ZUR BEHANDLUNG VON ERKRANKUNGEN, STÖRUNGEN ODER LÄSIONEN DES ZNS

SPC Number:

Dates

Filing date:

09/12/2010

Grant date:

11/02/2015

EP Publication Date:

11/02/2015

PCT Publication Date:

16/06/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/10/2012

EP B1 Publication Date:

11/02/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

09/12/2015

Expiration date:

09/12/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

09/12/2010

 

 

Name:

Quark Pharmaceuticals Inc.

Address:

6501 Dumbarton Circle, Fremont, California 94555, United States (US)

Inventor

1

Name:

ALPERT Evgenia

Address:

Israel (IL)

2

Name:

FEINSTEIN Elena

Address:

Israel (IL)

3

Name:

SPIVAK Igor

Address:

Israel (IL)

4

Name:

LAHAV Ron

Address:

Israel (IL)

Priority

1

Priority Number:

267835 P

Priority Date:

09/12/2009

Priority Country:

United States (US)

2

Priority Number:

319894 P

Priority Date:

01/04/2010

Priority Country:

United States (US)

Classification

Main IPC Class:

C12N 15/113;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages